These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28446138)

  • 1. Assessing the complexity of interventions within systematic reviews: development, content and use of a new tool (iCAT_SR).
    Lewin S; Hendry M; Chandler J; Oxman AD; Michie S; Shepperd S; Reeves BC; Tugwell P; Hannes K; Rehfuess EA; Welch V; Mckenzie JE; Burford B; Petkovic J; Anderson LM; Harris J; Noyes J
    BMC Med Res Methodol; 2017 Apr; 17(1):76. PubMed ID: 28446138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of the intervention Complexity Assessment Tool for Systematic Reviews within a Cochrane review: an illustrative case study.
    Cadogan CA; Rankin A; Lewin S; Hughes CM
    HRB Open Res; 2020; 3():31. PubMed ID: 32596632
    [No Abstract]   [Full Text] [Related]  

  • 3. Applying the intervention Complexity Assessment Tool to brief interventions targeting long-term benzodiazepine receptor agonist use in primary care: Lessons learned.
    Barry A; Lewin S; Cadogan CA
    BMC Prim Care; 2022 Jul; 23(1):175. PubMed ID: 35842593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Series: Clinical Epidemiology in South Africa. Paper 3: Logic models help make sense of complexity in systematic reviews and health technology assessments.
    Rohwer A; Pfadenhauer L; Burns J; Brereton L; Gerhardus A; Booth A; Oortwijn W; Rehfuess E
    J Clin Epidemiol; 2017 Mar; 83():37-47. PubMed ID: 27498377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventions.
    Wilkinson J; Heal C; Antoniou GA; Flemyng E; Alfirevic Z; Avenell A; Barbour G; Brown NJL; Carlisle J; Clarke M; Dicker P; Dumville JC; Grey A; Grohmann S; Gurrin L; Hayden JA; Heathers J; Hunter KE; Lasserson T; Lam E; Lensen S; Li T; Li W; Loder E; Lundh A; Meyerowitz-Katz G; Mol BW; O'Connell NE; Parker L; Redman BK; Seidler L; Sheldrick KA; Sydenham E; Torgerson D; van Wely M; Wang R; Bero L; Kirkham JJ
    BMJ Open; 2024 Mar; 14(3):e084164. PubMed ID: 38471680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards a taxonomy of logic models in systematic reviews and health technology assessments: A priori, staged, and iterative approaches.
    Rehfuess EA; Booth A; Brereton L; Burns J; Gerhardus A; Mozygemba K; Oortwijn W; Pfadenhauer LM; Tummers M; van der Wilt GJ; Rohwer A
    Res Synth Methods; 2018 Mar; 9(1):13-24. PubMed ID: 28677339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of interventions that assist caregivers to support people with dementia living in the community: a systematic review.
    Parker D; Mills S; Abbey J
    Int J Evid Based Healthc; 2008 Jun; 6(2):137-72. PubMed ID: 21631819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A research and development agenda for systematic reviews that ask complex questions about complex interventions.
    Noyes J; Gough D; Lewin S; Mayhew A; Michie S; Pantoja T; Petticrew M; Pottie K; Rehfuess E; Shemilt I; Shepperd S; Sowden A; Tugwell P; Welch V
    J Clin Epidemiol; 2013 Nov; 66(11):1262-70. PubMed ID: 23953084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AHRQ series on complex intervention systematic reviews-paper 2: defining complexity, formulating scope, and questions.
    Kelly MP; Noyes J; Kane RL; Chang C; Uhl S; Robinson KA; Springs S; Butler ME; Guise JM
    J Clin Epidemiol; 2017 Oct; 90():11-18. PubMed ID: 28720514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conducting systematic reviews of economic evaluations.
    Gomersall JS; Jadotte YT; Xue Y; Lockwood S; Riddle D; Preda A
    Int J Evid Based Healthc; 2015 Sep; 13(3):170-8. PubMed ID: 26288063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multidimensional approach to assessing intervention fidelity in a process evaluation of audit and feedback interventions to reduce unnecessary blood transfusions: a study protocol.
    Lorencatto F; Gould NJ; McIntyre SA; During C; Bird J; Walwyn R; Cicero R; Glidewell L; Hartley S; Stanworth SJ; Foy R; Grimshaw JM; Michie S; Francis JJ;
    Implement Sci; 2016 Dec; 11(1):163. PubMed ID: 27955683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AHRQ series on complex intervention systematic reviews-paper 3: adapting frameworks to develop protocols.
    Butler M; Epstein RA; Totten A; Whitlock EP; Ansari MT; Damschroder LJ; Balk E; Bass EB; Berkman ND; Hempel S; Iyer S; Schoelles K; Guise JM
    J Clin Epidemiol; 2017 Oct; 90():19-27. PubMed ID: 28720510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventions.
    Wilkinson J; Heal C; Antoniou GA; Flemyng E; Alfirevic Z; Avenell A; Barbour V; Brown NJL; Carlisle J; Clarke M; Dicker P; Dumville J; Grey A; Grohmann S; Gurrin LC; Hayden JA; Heathers J; Hunter KE; Lasserson T; Lam E; Lensen S; Li T; Li W; Loder E; Lundh A; Meyerowitz-Katz G; Mol BW; O' Connell NE; Parker L; Redman BK; Seidler AL; Sheldrick KA; Sydenham E; Torgerson DJ; van Wely M; Wang R; Bero L; Kirkham JJ
    medRxiv; 2023 Nov; ():. PubMed ID: 37873409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complex interventions and their implications for systematic reviews: A pragmatic approach.
    Petticrew M; Anderson L; Elder R; Grimshaw J; Hopkins D; Hahn R; Krause L; Kristjansson E; Mercer S; Sipe T; Tugwell P; Ueffing E; Waters E; Welch V
    Int J Nurs Stud; 2015 Jul; 52(7):1211-6. PubMed ID: 25661527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of Bias in Systematic Reviews of Non-Randomized Studies of Adverse Cardiovascular Effects of Thiazolidinediones and Cyclooxygenase-2 Inhibitors: Application of a New Cochrane Risk of Bias Tool.
    Bilandzic A; Fitzpatrick T; Rosella L; Henry D
    PLoS Med; 2016 Apr; 13(4):e1001987. PubMed ID: 27046153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A tool to characterize the components of pharmacist interventions in clinical pharmacy services: the DEPICT project.
    Correr CJ; Melchiors AC; de Souza TT; Rotta I; Salgado TM; Fernandez-Llimos F
    Ann Pharmacother; 2013; 47(7-8):946-52. PubMed ID: 23757389
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.